ClinicalTrials.gg
CompletedNCT06042036SPIRALUpdated Oct 13, 2026

Adherence to Low Tidal Volume in the Transition to Spontaneous Ventilation in Patients With Acute Respiratory Failure

An observational study in Respiration, Artificial, Acute Hypoxemic Respiratory Failure and Respiratory Insufficiency, sponsored by University of Sao Paulo General Hospital. Completed at 10 sites in 10 countries. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by University of Sao Paulo General Hospital · Observational

Updated Oct 13, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
431
Ages
18 Years to 110 Years
Sex
All
01

Study summary

The goal of this observational study is to estimate the prevalence of the use of protective ventilation with low tidal volume ventilation in the transition of spontaneous ventilation modes in patients with hypoxemic acute respiratory failure in ICUs in Latin America and its association with patient outcomes.

The main questions it aims to answer are:

  • what is the prevalence of the use of low tidal volume ventilation (VT \<8 mL/kg of predicted body weight) in the first 24 hours of spontaneous ventilation modes in patients with hypoxemic acute respiratory failure?
  • Is there an association between the rate of adherence to low tidal volume ventilation in spontaneous ventilation modes and the ability to stay off ventilatory support and mortality?

Participants are patients with acute respiratory failure under mechanical ventilation. Investigators will collect data on the ventilatory parameters of participants

  • 24 hours before they begin to be ventilated with spontaneous modes of ventilation
  • during the first 24 hours of spontaneous ventilation

Investigators will collect several patient-centered clinical outcomes at 28 days after study inclusion, including ventilator-free days and mortality

Read the detailed description

Investigators will conduct a cohort study in Intensive Care Units (ICUs) across Latin America, aiming to include 422 patients with Hypoxemic Acute Respiratory Failure (ARF) and under invasive mechanical ventilation.

The goal of this observational study is to estimate the prevalence of the use of protective ventilation with low tidal volume ventilation in the transition of spontaneous ventilation modes in patients with hypoxemic acute respiratory failure in ICUs in Latin America

The primary objectives are to determine the prevalence of low tidal volume ventilation (VT \< 8 mL/kg of predicted body weight) during the initial 24 hours of spontaneous ventilatory modes in patients diagnosed with hypoxemic ARF and its association with clinically important patient outcomes. Investigators are interested in assessing the rate of adherence to low tidal volume ventilation, defined as maintaining VT \< 8 mL/kg of predicted body weight during the first 24 hours of ventilation in spontaneous mode.They are also interested in measuring the number of days that patients are alive and not receiving ventilatory support and survival at 28 days.

Investigators will also measure the proportion of patients experiencing significant asynchrony during the transition to spontaneous mechanical ventilation, who revert to sedation and controlled mechanical ventilation within the first 24 hours or at any point during mechanical ventilation.

02

Conditions studied

  • Respiration, Artificial
  • Acute Hypoxemic Respiratory Failure
  • Respiratory Insufficiency

Keywords

  • Adherence, Treatment
  • intensive care units
03

In context

Respiratory Insufficiency

1,369 studies on the registry are indexed under Respiratory Insufficiency; 264 are open to participants now.

This study's enrollment of 431 is above the median of 100 across 455 observational studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 611 studies on the registry; 98 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with hypoxemic ARF, defined as a PaO2/FIO2 ratio \<300 mmHg, under controlled invasive mechanical ventilation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18 years
  • Patients with hypoxemic ARF, defined as a PaO2/FIO2 ratio \<300 mmHg, under controlled invasive mechanical ventilation, with an expected duration of MV of at least 24h.
  • Patients transitioning to spontaneous ventilation modes (PSV, PAV Plus, NAVA or APRV)

Exclusion criteria

Exclusion Criteria:

  • Tracheostomized patients.
  • Decision not to maintain or add life support measures on the day of assessment (palliative care).
  • Patient in ECMO.
  • Air fistula or barotrauma that prevents adequate tidal volume monitoring.
  • Severe injuries to the central nervous system that result in abolished or very high respiratory drive, for whom it is not possible to maintain protective tidal volume.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
431 participants (actual)
Patient registry
No

Groups and cohorts

  • acute hypoxemic respiratory failure

    Patients with acute hypoxemic respiratory failure transitioning to a spontaneous mode of mechanical ventilation ( PSV, APRV, NAVA, PAV+, CPAP)

    Other: Spontaneous mode of mechanical ventilation

Interventions

  • OtherSpontaneous mode of mechanical ventilation

    any mode of mechanical ventilation classified as spontaneous or proportional, mainly pressure support ventilation, but also CPAP, APRV, NAVA, PAV+

    Also known as: spontaneous ventilation

06

What researchers measure

Primary outcomes

  1. Low tidal volume

    Low tidal volume, defined as less or equal to 8 mLs per Kg of predicted body weight

    Time frame: 24 hours

  2. Ventilator- free days

    number of days alive and not receiving invasive mechanical ventilation after transition to spontaneous ventilation

    Time frame: 28 days

Secondary outcomes

  1. Hospital mortality

    mortality in the hospital

    Time frame: 28 days

  2. Rate of patient-ventilator asynchrony

    presence of patient asynchrony 24h after transition to a spontaneous mode of mechanical ventilation

    Time frame: 24 hours

  3. Number of participants that return to controlled mechanical ventilation in the first 24 hours

    return to controlled mechanical ventilation in the first 24 hours after transition to spontaneous ventilation

    Time frame: 24 hours

  4. Number of participants that return to sedation in the first 24 hours

    return to sedation in the first 24 hours after transition to spontaneous ventilation

    Time frame: 24 hours

  5. Number of participants that return to controlled mechanical ventilation after transition to spontaneous ventilation

    return to controlled mechanical ventilation any time after transition to spontaneous ventilation

    Time frame: 28 days

  6. Number of participants that return to sedation after transition to spontaneous ventilation

    return to sedation any time after transition to spontaneous ventilation

    Time frame: 28 days

  7. Number of participants with PEEP and FIO2 compatible with the ARDSnet PEEP/FIO2 table

    adherence to ARDSnet low PEEP/FIO2 table after transition to spontaneous ventilation

    Time frame: 24 hours

  8. Number of participants who were extubated

    Extubation and discontinuation of mechanical ventilation after the transition to spontaneous mode

    Time frame: 28 days

  9. Rate of reintubation

    Reintubation after transition to spontaneous mode and extubation

    Time frame: 28 days

07

Study locations

10 sites
  • Sanatorio Juncal SA
    Buenos Aires, Argentina
  • Hospital Municipal Boliviano Holandés, Universidad Mayor de San Andrés
    La Paz, Bolivia
  • Hospital das Clínicas -HCFMUSP
    São Paulo, São Paulo 05403010, Brazil
  • Pontificia Universidad Catolica de Chile
    Santiago, Chile
  • Clinica Universidad de la Sabana
    Chía, Colombia
  • Hospital Eugenio Espejo
    Quito, Ecuador
  • Hospital Civil Fray Antonio Alcalde
    Guadalajara, Mexico
  • Hospital San Roque
    Asunción, Paraguay
  • Hospital Rebagliati
    Lima, Peru
  • Hospital Espanol
    Montevideo, Uruguay
08

References and documents

Individual participant data

Plan to share: Undecided — data sharing will follow Institutional rules for patient data protection

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 13, 2026
Sites
1 site added, 1 site removed
Show site
  • Hospital das Clínicas -HCFMUSP · São Paulo, Brazil
Show 1 removed
  • Hospital das Clínicas -HCFMUSP · Sao Paulo, Brazil
Oct 13, 2026
Primary completion
Jun 12, 2024→Jul 15, 2024 (actual)
Oct 13, 2026
Study completion
Oct 12, 2024→Aug 15, 2024 (actual)
Oct 13, 2026
Enrollment
422 (estimated)→431 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Hospital das Clínicas -HCFMUSP · São Paulo, Brazil
    Show 1 removed
    • Hospital das Clínicas -HCFMUSP · Sao Paulo, Brazil
    Primary completion Jun 12, 2024→Jul 15, 2024 (now actual)
    Study completion Oct 12, 2024→Aug 15, 2024 (now actual)
    Enrollment 422 (estimated)→431 (actual)
    + 3 other changes: verification date, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06042036
Collaborators
Brazilian Research In Intensive Care Network, Latin American Intensive Care Network (LIVEN)
Responsible party
Sponsor
First posted
Sep 18, 2023
Start date
Jun 12, 2023
Primary completion
Jul 15, 2024
Completion
Aug 15, 2024
Last update
Oct 13, 2026

Study contacts

JULIANA C FERREIRA, MD
principal investigator · University of Sao Paulo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion